Here we reported that a novel variant of ER-α, ER-α36, that is highly expressed on the plasma membrane of Hec1A endometrial cancer cells and in the endometrial cancer specimens from patients who had been treated with tamoxifen for at least three years. Here, ESR1 is linked to endometrial cancer.